{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:40:37Z","timestamp":1789753237093,"version":"4.0.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,7,9]],"date-time":"2015-07-09T00:00:00Z","timestamp":1436400000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004263","name":"FAPERGS","doi-asserted-by":"crossref","award":["10\/0036-5"],"award-info":[{"award-number":["10\/0036-5"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fish Physiol Biochem"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s10695-015-0093-2","type":"journal-article","created":{"date-parts":[[2015,7,8]],"date-time":"2015-07-08T12:54:05Z","timestamp":1436360045000},"page":"1383-1392","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Investigation into effects of antipsychotics on ectonucleotidase and adenosine deaminase in zebrafish brain"],"prefix":"10.1007","volume":"41","author":[{"given":"Kelly Juliana","family":"Seibt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"da Luz Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio Reis","family":"Bogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Roberto","family":"Senger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Denise","family":"Bonan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,9]]},"reference":[{"key":"93_CR1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.tins.2008.10.001","volume":"32","author":"MP Abbracchio","year":"2009","unstructured":"Abbracchio MP, Burnstock G, Verkhratsky A, Zimmermann H (2009) Purinergic signaling in the nervous system: an overview. Trends Neurosci 32:19\u201329","journal-title":"Trends Neurosci"},{"key":"93_CR2","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1073\/pnas.97.14.8104","volume":"97","author":"A Abi-Dargham","year":"2000","unstructured":"Abi-Dargham A, Rodenhiser J, Printz D, Zea-Ponce Y, Gil R, Kegeles LS, Weiss R, Cooper TB, Mann JJ, Van Heertum RL, Gorman JM, Laruelle M (2000) Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci USA 97:8104\u20138109","journal-title":"Proc Natl Acad Sci USA"},{"key":"93_CR3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.brainres.2007.06.103","volume":"1174","author":"L Appelbaum","year":"2007","unstructured":"Appelbaum L, Skariah G, Mourrain P, Mignot E (2007) Comparative expression of P2X receptors and ecto-nucleoside triphosphate diphosphohydrolase 3 in hypocretin and sensory neurons in zebrafish. Brain Res 1174:66\u201375","journal-title":"Brain Res"},{"key":"93_CR4","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1111\/j.1471-4159.1993.tb09804.x","volume":"61","author":"JM Barnes","year":"1993","unstructured":"Barnes JM, Murphy PA, Kirkham D, Henley JM (1993) Interaction of guanine nucleotides with [3H] kainate and 6-[3H] cyano-7-nitroquinoxaline-2,3-dione binding in goldfish brain. J Neurochem 61:1685\u20131691","journal-title":"J Neurochem"},{"key":"93_CR5","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.gep.2008.11.006","volume":"9","author":"W Boehmler","year":"2009","unstructured":"Boehmler W, Petko J, Woll M, Frey C, Thisse B, Thisse C, Canfield VA, Levenson R (2009) Identification of zebrafish A2 adenosine receptors and expression in developing embryos. Gene Expr Patterns 9:144\u2013151","journal-title":"Gene Expr Patterns"},{"key":"93_CR6","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.tips.2006.10.008","volume":"27","author":"D Boison","year":"2006","unstructured":"Boison D (2006) Adenosine kinase, epilepsy and stroke: mechanisms and 398 therapies. Trends Pharmacol Sci 27:652\u2013658","journal-title":"Trends Pharmacol Sci"},{"key":"93_CR7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1471-4159.2006.04386.x","volume":"101","author":"J Borycz","year":"2007","unstructured":"Borycz J, Pereira MF, Melani A, Rodrigues RJ, K\u00f6falvi A, Panlilio L, Pedata F, Goldberg SR, Cunha RA, Ferr\u00e9 S (2007) Differential glutamate-dependent and glutamate-independent adenosine A1 receptor mediated modulation of dopamine release in different striatal compartments. J Neurochem 101:355\u2013363","journal-title":"J Neurochem"},{"key":"93_CR8","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:218\u2013254","journal-title":"Anal Biochem"},{"key":"93_CR9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1054-3589(08)60076-9","volume":"39","author":"JM Brundege","year":"1997","unstructured":"Brundege JM, Dunwiddie TV (1997) Role of adenosine as a modulator of synaptic activity in the central nervous system. Adv Pharmacol 39:353\u2013391","journal-title":"Adv Pharmacol"},{"key":"93_CR10","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1152\/physrev.00043.2006","volume":"87","author":"G Burnstock","year":"2007","unstructured":"Burnstock G (2007) Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 87:659\u2013797","journal-title":"Physiol Rev"},{"key":"93_CR11","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrd2605","volume":"7","author":"G Burnstock","year":"2008","unstructured":"Burnstock G (2008) Purinergic signalling and disorders of the central nervous system. Nat Rev Drug Discov 7:575\u2013590","journal-title":"Nat Rev Drug Discov"},{"key":"93_CR12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1590\/S0100-879X2008005000037","volume":"42","author":"G Burnstock","year":"2009","unstructured":"Burnstock G (2009) Purinergic signalling: past, present and future. Braz J Med Biol Res 42:3\u20138","journal-title":"Braz J Med Biol Res"},{"key":"93_CR13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0026-895X(25)13120-9","volume":"44","author":"MA Carfagna","year":"1993","unstructured":"Carfagna MA, Muhoberac BB (1993) Interaction of tricyclic drug analogs with synaptic plasma membranes: structure-mechanism relationships in inhibition of neuronal Na+\/K(+)-ATPase activity. Mol Pharmacol 44:129\u2013141","journal-title":"Mol Pharmacol"},{"key":"93_CR14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0003-2697(86)90640-8","volume":"157","author":"KM Chan","year":"1986","unstructured":"Chan KM, Delfert D, Junger KD (1986) A direct colorimetric assay for Ca2+-stimulated ATPase activity. Anal Biochem 157:375\u2013380","journal-title":"Anal Biochem"},{"key":"93_CR15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.aquatox.2004.05.004","volume":"69","author":"WY Chen","year":"2004","unstructured":"Chen WY, John JAC, Lin CH, Lin HF, Wu SC, Lin CH, Chang CY (2004) Expression of metallothionen gene during embryonic and early larval development in zebrafish. Aquat Toxicol 69:215\u2013227","journal-title":"Aquat Toxicol"},{"issue":"6","key":"93_CR16","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1192\/bjp.bp.109.066217","volume":"196","author":"NA Crossley","year":"2010","unstructured":"Crossley NA, Constante M, McGuire P, Power P (2010) Efficacy of atypical v. typical antipsychotics in the treatment of early psychosis: meta-analysis. Br J Psychiatry 196(6):434\u2013439","journal-title":"Br J Psychiatry"},{"key":"93_CR17","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.2174\/138161208784480090","volume":"14","author":"RA Cunha","year":"2008","unstructured":"Cunha RA, Ferr\u00e9 S, Vaugeois JM, Chen JF (2008) Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders. Curr Pharm Des 14:1512\u20131524","journal-title":"Curr Pharm Des"},{"key":"93_CR18","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s00213-002-1362-1","volume":"166","author":"OP Dall\u2019Igna","year":"2003","unstructured":"Dall\u2019Igna OP, da Silva AL, Dietrich MO, Hoffmann A, de Oliveira RV, Souza DO, Lara DR (2003) Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-d-aspartate receptor antagonist MK-801 in mice. Psychopharmacology 166:258\u2013263","journal-title":"Psychopharmacology"},{"key":"93_CR19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00008877-200503000-00002","volume":"16","author":"RV Oliveira de","year":"2005","unstructured":"de Oliveira RV, Dall\u2019Igna OP, Tort AB, Schuh JF, Neto PF, Santos Gomes MW, Souza DO, Lara DR (2005) Effect of subchronic caffeine treatment on MK-801-induced changes in locomotion, cognition and ataxia in mice. Behav Pharmacol 16:79\u201384","journal-title":"Behav Pharmacol"},{"key":"93_CR20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev.neuro.24.1.31","volume":"24","author":"TV Dunwiddie","year":"2001","unstructured":"Dunwiddie TV, Massino SA (2001) The role and regulation of adenosine in central nervous system. Annu Rev Neurosci 24:31\u201355","journal-title":"Annu Rev Neurosci"},{"key":"93_CR21","first-page":"107","volume":"2","author":"S Ferr\u00e9","year":"1997","unstructured":"Ferr\u00e9 S (1997) Adenosine\u2013dopamine interactions in the ventral striatum. Implications for the treatment of schizophrenia. Psychopharmacology 2:107\u2013120","journal-title":"Psychopharmacology"},{"key":"93_CR22","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1471-4159.2007.05196.x","volume":"105","author":"S Ferr\u00e9","year":"2008","unstructured":"Ferr\u00e9 S (2008) An update on the mechanisms of the psychostimulant effects of caffeine. J Neurochem 105:1067\u20131079","journal-title":"J Neurochem"},{"key":"93_CR23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0301-0082(97)00013-0","volume":"52","author":"R Franco","year":"1997","unstructured":"Franco R, Casado V, Ciruela F, Saura C, Mallol J, Canela EI, Lluis C (1997) Cell surface adenosine deaminase: much more than an ecto-enzyme. Prog Neurobiol 52:283\u2013294","journal-title":"Prog Neurobiol"},{"key":"93_CR24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0074-7742(05)63007-3","volume":"63","author":"BB Fredholm","year":"2005","unstructured":"Fredholm BB, Chen JF, Cunha RA, Svenningsson P, Vaugeois JM (2005) Adenosine and brain function. Int Rev Neurobiol 63:191\u2013270","journal-title":"Int Rev Neurobiol"},{"key":"93_CR25","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0091-3057(00)00422-6","volume":"67","author":"R Gerlai","year":"2000","unstructured":"Gerlai R, Lahav S, Guo S, Rosenthal A (2000) Drinks like a fish: zebrafish (Danio rerio) as a behavior genetic model to study alcohol effects. Pharmacol Biochem Behav 67:773\u2013782","journal-title":"Pharmacol Biochem Behav"},{"key":"93_CR26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ntt.2006.01.013","volume":"28","author":"NJ Giacomini","year":"2006","unstructured":"Giacomini NJ, Rose B, Kobayashi K, Guo S (2006) Antipsychotics produce locomotor impairment in larval zebrafish. Neurotoxicol Teratol 28:245\u2013250","journal-title":"Neurotoxicol Teratol"},{"key":"93_CR27","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0006-8993(98)00743-4","volume":"2","author":"K Golembiowska","year":"1998","unstructured":"Golembiowska K, Zylewska A (1998) Agonists of A1 and A2A adenosine receptors attenuate methamphetamine-induced overflow of dopamine in rat striatum. Brain Res 2:202\u2013209","journal-title":"Brain Res"},{"key":"93_CR28","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1177\/0269881107077221","volume":"21","author":"P Heiser","year":"2007","unstructured":"Heiser P, Enning F, Krieg JC, Vedder H (2007) Effects of haloperidol, clozapine and olanzapine on the survival of human neuronal and immune cells in vitro. J Psychopharmacol 21:851\u2013856","journal-title":"J Psychopharmacol"},{"key":"93_CR29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1124\/mol.59.1.127","volume":"59","author":"C Herrera","year":"2001","unstructured":"Herrera C, Casad\u00f3 V, Ciruela F, Schofield P, Mallol J, Lluis C, Franco R (2001) Adenosine A2B receptors behave as an alternative anchoring protein for cell surface adenosine deaminase in lymphocytes and cultured cells. Mol Pharmacol 59:127\u2013134","journal-title":"Mol Pharmacol"},{"key":"93_CR30","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0301-0082(96)00037-8","volume":"50","author":"K Inoue","year":"1996","unstructured":"Inoue K, Koizumi S, Ueno S (1996) Implication of ATP receptors in brain functions. Prog Neurobiol 50:483\u2013492","journal-title":"Prog Neurobiol"},{"key":"93_CR31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1254\/jphs.09142FP","volume":"111","author":"T Ishida","year":"2009","unstructured":"Ishida T, Obara Y, Kamei C (2009) Effects of some antipsychotics and a benzodiazepine hypnotic on the sleep-wake pattern in an animal model of schizophrenia. J Pharmacol Sci 111:44\u201352","journal-title":"J Pharmacol Sci"},{"key":"93_CR33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00213-002-1052-z","volume":"162","author":"A Karow","year":"2002","unstructured":"Karow A, Naber D (2002) Subjective well-being and quality of life under atypical antipsychotic treatment. Psychopharmacology 162:3\u201310","journal-title":"Psychopharmacology"},{"key":"93_CR34","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0306-4522(03)00566-9","volume":"121","author":"S Kucenas","year":"2003","unstructured":"Kucenas S, Li Z, Cox JA, Egan TM, Voigt MM (2003) Molecular characterization of the zebrafish P2X receptor subunit gene family. Neuroscience 121:935\u2013945","journal-title":"Neuroscience"},{"key":"93_CR35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1054\/mehy.1999.0003","volume":"54","author":"DR Lara","year":"2000","unstructured":"Lara DR, Souza DO (2000) Schizophrenia: a purinergic hypothesis. Med Hypotheses 54:157\u2013166","journal-title":"Med Hypotheses"},{"key":"93_CR36","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000054925","volume":"44","author":"DR Lara","year":"2001","unstructured":"Lara DR, Vianna MR, de Paris F, Quevedo J, Oses JP, Battastini AM, Sarkis JJ, Souza DO (2001) Chronic treatment with clozapine, but not haloperidol, increase striatal ecto-5\u2032-nucleotidase activity in rats. Neuropsychobiology 44:99\u2013102","journal-title":"Neuropsychobiology"},{"key":"93_CR37","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.pnpbp.2006.02.002","volume":"30","author":"DR Lara","year":"2006","unstructured":"Lara DR, Dall\u2019Igna OP, Ghisolfi ES, Brunstein MG (2006) Involvement of adenosine in the neurobiology of schizophrenia and its therapeutic implications. Prog Neuropsychopharmacol Biol Psychiatry 30:617\u2013629","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"93_CR38","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0165-0173(99)00054-5","volume":"2","author":"M Laruelle","year":"2000","unstructured":"Laruelle M (2000) The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies. Brain Res Rev 2:371\u2013384","journal-title":"Brain Res Rev"},{"key":"93_CR39","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1471-4159.2001.00607.x","volume":"79","author":"S Latini","year":"2001","unstructured":"Latini S, Pedata F (2001) Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem 79:463\u2013484","journal-title":"J Neurochem"},{"key":"93_CR40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0006-3223(90)90429-6","volume":"1","author":"PB Lucas","year":"1990","unstructured":"Lucas PB, Pickar D, Kelsoe J, Rapaport M, Pato C, Hommer D (1990) Effects of the acute administration of caffeine in patients with schizophrenia. Biol Psychiatry 1:35\u201340","journal-title":"Biol Psychiatry"},{"key":"93_CR41","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ygeno.2005.11.003","volume":"87","author":"K Mass\u00e9","year":"2006","unstructured":"Mass\u00e9 K, Eason R, Bhamra S, Dale N, Jones EA (2006) Comparative genomic and expression analysis of the conserved NTPDase gene family in Xenopus. Genomics 87:366\u2013381","journal-title":"Genomics"},{"key":"93_CR42","first-page":"2","volume":"28","author":"J McGrath","year":"2004","unstructured":"McGrath J, Saha S, Welham J, El Saadi O, MacCauley C, Chant D (2004) A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med 28:2\u201313","journal-title":"BMC Med"},{"key":"93_CR43","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev-med-050911-161504","volume":"64","author":"HY Meltzer","year":"2013","unstructured":"Meltzer HY (2013) Update on typical and atypical antipsychotic drugs. Annu Rev Med 64:393\u2013406","journal-title":"Annu Rev Med"},{"key":"93_CR44","first-page":"25","volume":"63","author":"HY Meltzer","year":"2002","unstructured":"Meltzer HY, Davidson M, Glassman AH, Vieweg WV (2002) Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatment. J Clin Psychiatry 63:25\u201329","journal-title":"J Clin Psychiatry"},{"key":"93_CR45","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0079-6123(09)17911-6","volume":"179","author":"JA Morris","year":"2009","unstructured":"Morris JA (2009) Zebrafish: a model system to examine the neurodevelopmental basis of schizophrenia. Prog Brain Res 179:97\u2013106","journal-title":"Prog Brain Res"},{"key":"93_CR46","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00424-006-0060-y","volume":"452","author":"RA North","year":"2006","unstructured":"North RA, Verkhratsky A (2006) Purinergic transmission in the central nervous system. Pflugers Arch 452:479\u2013485","journal-title":"Pflugers Arch"},{"key":"93_CR47","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuint.2006.08.002","volume":"50","author":"B Ozyurt","year":"2007","unstructured":"Ozyurt B, Sarsilmaz M, Akpolat N, Ozyurt H, Akyol O, Herken H, Kus I (2007) The protective effects of omega-3 fatty acids against MK-801-induced neurotoxicity in prefrontal cortex of rat. Neurochem Int 50:196\u2013202","journal-title":"Neurochem Int"},{"key":"93_CR48","first-page":"453","volume":"13","author":"L Pani","year":"2009","unstructured":"Pani L (2009) The need for individualised antipsychotic drug therapy in patients with schizophrenia. Eur Rev Med Pharmacol Sci 13:453\u2013459","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"93_CR49","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0893-133X(98)00051-7","volume":"20","author":"A Pinna","year":"1999","unstructured":"Pinna A, Wardas J, Cozzolino A, Morelli M (1999) Involvement of adenosine A2A receptors in the induction of c-fos expression by clozapine and haloperidol. Neuropsychopharmacology 20:44\u201351","journal-title":"Neuropsychopharmacology"},{"key":"93_CR50","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/S0024-3205(03)00596-4","volume":"73","author":"EP Rico","year":"2003","unstructured":"Rico EP, Senger MR, Fauth MG, Dias RD, Bogo MR, Bonan CD (2003) ATP and ADP hydrolysis in brain membranes of zebrafish (Danio rerio). Life Sci 73:2071\u20132082","journal-title":"Life Sci"},{"key":"93_CR51","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ntt.2006.05.001","volume":"28","author":"EP Rico","year":"2006","unstructured":"Rico EP, Rosemberg DB, Senger MR, Arizi MB, Bernardi GF, Dias RD, Bogo MR, Bonan CD (2006) Methanol alters ecto-nucleotidases and acetylcholinesterase in zebrafish brain. Neurotoxicol Teratol 28:489\u2013496","journal-title":"Neurotoxicol Teratol"},{"key":"93_CR52","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.lfs.2007.09.019","volume":"81","author":"DB Rosemberg","year":"2007","unstructured":"Rosemberg DB, Rico EP, Guidoti MR, Dias RD, Souza DO, Bonan CD (2007) Adenosine deaminase-related genes: molecular identification, tissue expression pattern and truncated alternative splice isoform in adult zebrafish (Danio rerio). Life Sci 81:1526\u20131534","journal-title":"Life Sci"},{"key":"93_CR53","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.cbpb.2008.06.001","volume":"151","author":"DB Rosemberg","year":"2008","unstructured":"Rosemberg DB, Rico EP, Senger MR, Dias RD, Bogo MR, Bonan CD (2008) Kinetic characterization of adenosine deaminase activity in zebrafish (Danio rerio) brain. Comp Biochem Physiol B 151:96\u2013101","journal-title":"Comp Biochem Physiol B"},{"key":"93_CR54","doi-asserted-by":"crossref","first-page":"17610","DOI":"10.1074\/jbc.273.28.17610","volume":"273","author":"CA Saura","year":"1998","unstructured":"Saura CA, Mallol J, Canela EI, Lluis C, Franco R (1998) Adenosine deaminase and A1 adenosine receptors internalize together following agonist-induced receptor desensitization. J Biol Chem 273:17610\u201317617","journal-title":"J Biol Chem"},{"key":"93_CR56","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/syn.20303","volume":"60","author":"P Seeman","year":"2006","unstructured":"Seeman P, Schwarz J, Chen JF, Szechtman H, Perreault M, McKnight GS, Roder JC, Quirion R, Boksa P, Srivastava LK, Yanai K, Weinshenker D, Sumiyoshi T (2006) Psychosis pathways converge via D2 high dopamine receptors. Synapse 60:319\u2013346","journal-title":"Synapse"},{"key":"93_CR57","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.tiv.2008.10.003","volume":"23","author":"KJ Seibt","year":"2009","unstructured":"Seibt KJ, Oliveira RL, Rico EP, Dias RD, Bogo MR, Bonan CD (2009) Antipsychotic drugs inhibit nucleotide hydrolysis in zebrafish (Danio rerio) brain membranes. Toxicol In Vitro 23:78\u201382","journal-title":"Toxicol In Vitro"},{"key":"93_CR58","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.bbr.2010.06.014","volume":"214","author":"KJ Seibt","year":"2010","unstructured":"Seibt KJ, da Oliveira RL, Zimmermann FF, Capiotti KM, Bogo MR, Ghisleni G, Bonan CD (2010) Antipsychotic drugs prevent the motor hyperactivity induced by psychotomimetic MK-801 in zebrafish (Danio rerio). Behav Brain Res 214:417\u2013422","journal-title":"Behav Brain Res"},{"key":"93_CR59","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cbpc.2004.07.011","volume":"139","author":"MR Senger","year":"2004","unstructured":"Senger MR, Rico EP, Dias RD, Bogo MR, Bonan CD (2004) Ecto-5\u2032-nucleotidase activity in brain membranes of zebrafish (Danio rerio). Comp Biochem Physiol B: Biochem Mol Biol 139:203\u2013207","journal-title":"Comp Biochem Physiol B: Biochem Mol Biol"},{"key":"93_CR60","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jcis.2008.01.034","volume":"320","author":"C Tessier","year":"2008","unstructured":"Tessier C, Nuss P, Staneva G, Wolf C (2008) Modification of membrane heterogeneity by antipsychotic drugs: an X-ray diffraction comparative study. J Colloid Interface Sci 320:469\u2013475","journal-title":"J Colloid Interface Sci"},{"key":"93_CR61","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(09)60995-8","volume":"374","author":"J Os van","year":"2009","unstructured":"van Os J, Kapur S (2009) Schizophrenia. Lancet 374:635\u2013645","journal-title":"Lancet"},{"key":"93_CR62","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1176\/appi.ajp.159.2.255","volume":"159","author":"J Volavka","year":"2002","unstructured":"Volavka J, Czobor P, Sheitman B, Lindenmayer JP, Citrome L, McEvoy JP, Cooper TB, Chakos M, Lieberman JA (2002) Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. Am J Psychiatry 159:255\u2013262","journal-title":"Am J Psychiatry"},{"key":"93_CR63","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.2741\/2995","volume":"13","author":"J Wardas","year":"2008","unstructured":"Wardas J (2008) Potential role of adenosine A2A receptors in the treatment of schizophrenia. Front Biosci 13:4071\u20134096","journal-title":"Front Biosci"},{"key":"93_CR64","doi-asserted-by":"crossref","first-page":"5266","DOI":"10.1016\/S0021-9258(18)60710-0","volume":"263","author":"MI Weisman","year":"1988","unstructured":"Weisman MI, Caiolfa VR, Parola AH (1988) Adenosine deaminase-complexing protein from bovine kidney. Isolation of two distinct subunits. J Biol Chem 263:5266\u20135270","journal-title":"J Biol Chem"},{"key":"93_CR65","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bbamcr.2008.01.024","volume":"1783","author":"GG Yegutkin","year":"2008","unstructured":"Yegutkin GG (2008) Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochim Biophys Acta 1783:673\u2013694","journal-title":"Biochim Biophys Acta"},{"key":"93_CR66","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/ddr.1097","volume":"52","author":"H Zimmermann","year":"2001","unstructured":"Zimmermann H (2001) Ecto-nucleotidases: some recent developments and a note on nomenclature. Drug Dev Res 52:44\u201356","journal-title":"Drug Dev Res"},{"key":"93_CR67","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/9780470032244.ch10","volume":"276","author":"H Zimmermann","year":"2006","unstructured":"Zimmermann H (2006) Ectonucleotidases in the nervous system. Novartis Found Symp 276:113\u2013128","journal-title":"Novartis Found Symp"}],"container-title":["Fish Physiology and Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10695-015-0093-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10695-015-0093-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10695-015-0093-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T02:50:06Z","timestamp":1748487006000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10695-015-0093-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,9]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["93"],"URL":"https:\/\/doi.org\/10.1007\/s10695-015-0093-2","relation":{},"ISSN":["0920-1742","1573-5168"],"issn-type":[{"value":"0920-1742","type":"print"},{"value":"1573-5168","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,9]]}}}